T-Track CMV
Commercial- Indications
- Cytomegalovirus infection, Transplantation monitoring
Company intelligence / Profile preview
Lophius Biosciences
Regensburg, Bavaria, Germanybayern-international.de ↗
- Ownership
- Private
- Employees
- ~28
- Development stage
- Commercial
01
Overview
Lophius Biosciences has commercialized a CE-marked diagnostic kit for individualized management of CMV risk in transplant patients. Its pipeline includes advanced clinical programs targeting improved differentiation between active and latent tuberculosis as well as early-stage development of a multiple sclerosis diagnostic. The company’s technology leverages T cell functional assessment to improve immunomonitoring and personalized medicine approaches in infectious and autoimmune diseases
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Diagnostic kitBiomarker-based diagnosticsBlood-based multi-marker solution
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
BL&H (exclusive distribution agreement for South Korea)Oxford Immunotec (licensing deals on T-cell assay IP)
Beyond the preview
Go deeper on Lophius Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lophius Biosciences.